Physicians frequently get asked by patients how to participate in a clinical trial. They may face a life-threatening or life-limiting condition reports Timothy M. Smith, Senior News Writer with the American Medical Association (AMA). Smith reports that for those patients that are not able to participate in a clinical trial, for whatever reason, the Food and Drug Administration (FDA) expanded access program offers a potential pathway to participate in a clinical trial and access advanced investigational therapies. The AMA recently adopted policy concerning this scenario: how should a physician respond to patient requests for treatments that are not yet approved by the FDA? When should a physician say no? When should they refer such a patient to another physician?
Follow the link to the AMA website to read more on this interesting topic. For more on the author see the link.Source: AMA